Document is current
Any future updates will be listed below
-
Authors
Lim, Yoong Wearn
Coles, Garry L.
Sandhu, Savreet K.
Johnson, David S.
Adler, Adam S. https://orcid.org/0000-0001-9301-0037
Stone, Erica L.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R44CA187852)
- License Information
-
More Information
Article History
Received: 29 October 2020
Accepted: 21 April 2021
First Online: 25 May 2021
Declarations
:
: Not applicable.
: Not applicable.
: All authors are salaried employees of GigaGen, a subsidiary of Grifols. GigaGen provided research funds for described studies. Y.W.L., G.L.C., D.S.J., A.S.A., and E.L.S. are inventors on provisional patent application 63/023,790 (assigned to GigaGen) describing therapeutic modalities for cancer that incorporate chemokines such as CCL5.
